BIOPLUS ACQUISITION CORP's ticker is and the CUSIP is G11217109. A total of 3 filers reported holding BIOPLUS ACQUISITION CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $185,617 | -4.0% | 18,451 | 0.0% | 0.00% | – |
| Q1 2023 | $193,366 | -48.8% | 18,451 | -50.0% | 0.00% | – |
| Q4 2022 | $377,876 | +104.3% | 36,902 | +100.0% | 0.00% | – |
| Q3 2022 | $185,000 | -0.5% | 18,451 | 0.0% | 0.00% | – |
| Q2 2022 | $186,000 | +1.1% | 18,451 | 0.0% | 0.00% | – |
| Q1 2022 | $184,000 | – | 18,451 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CLEAR STREET LLC | 19,249 | $209 | 0.00% |
| UBS Group AG | 50 | $542 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |